AN2 Therapeutics, Inc. (ANTX)
Nasdaq: ANTX · CIK 0001880438 · United States
Every official AN2 Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ANTX filings
AN2 Therapeutics, Inc. documents
- AN2 Therapeutics, Inc. 10-K 2026ANTX 10-K 2026: annual report for fiscal 2026
- AN2 Therapeutics, Inc. 10-K 2025ANTX 10-K 2025: annual report for fiscal 2025
- AN2 Therapeutics, Inc. 10-K 2024ANTX 10-K 2024: annual report for fiscal 2024
- AN2 Therapeutics, Inc. 10-K 2023ANTX 10-K 2023: annual report for fiscal 2023
- AN2 Therapeutics, Inc. 10-K 2022ANTX 10-K 2022: annual report for fiscal 2022
- AN2 Therapeutics, Inc. 10-Q 2026ANTX 10-Q 2026: quarterly report for fiscal 2026
- AN2 Therapeutics, Inc. 10-Q 2025ANTX 10-Q 2025: quarterly report for fiscal 2025
- AN2 Therapeutics, Inc. 10-Q 2024ANTX 10-Q 2024: quarterly report for fiscal 2024
- AN2 Therapeutics, Inc. 10-Q 2023ANTX 10-Q 2023: quarterly report for fiscal 2023
- AN2 Therapeutics, Inc. 10-Q 2022ANTX 10-Q 2022: quarterly report for fiscal 2022
- AN2 Therapeutics, Inc. 8-K 2026ANTX 8-K 2026: current report for fiscal 2026
- AN2 Therapeutics, Inc. 8-K 2025ANTX 8-K 2025: current report for fiscal 2025
- AN2 Therapeutics, Inc. 8-K 2024ANTX 8-K 2024: current report for fiscal 2024
- AN2 Therapeutics, Inc. 8-K 2023ANTX 8-K 2023: current report for fiscal 2023
- AN2 Therapeutics, Inc. 8-K 2022ANTX 8-K 2022: current report for fiscal 2022
- AN2 Therapeutics, Inc. DEF 14A 2026ANTX DEF 14A 2026: proxy statement for fiscal 2026
- AN2 Therapeutics, Inc. DEF 14A 2025ANTX DEF 14A 2025: proxy statement for fiscal 2025
- AN2 Therapeutics, Inc. DEF 14A 2024ANTX DEF 14A 2024: proxy statement for fiscal 2024
- AN2 Therapeutics, Inc. DEF 14A 2023ANTX DEF 14A 2023: proxy statement for fiscal 2023
- AN2 Therapeutics, Inc. DEF 14A 2022ANTX DEF 14A 2022: proxy statement for fiscal 2022
- AN2 Therapeutics, Inc. Form 4 2026ANTX Form 4 2026: insider trading filing for fiscal 2026
- AN2 Therapeutics, Inc. Form 4 2025ANTX Form 4 2025: insider trading filing for fiscal 2025
- AN2 Therapeutics, Inc. Form 4 2024ANTX Form 4 2024: insider trading filing for fiscal 2024
- AN2 Therapeutics, Inc. Form 4 2023ANTX Form 4 2023: insider trading filing for fiscal 2023
- AN2 Therapeutics, Inc. Form 4 2022ANTX Form 4 2022: insider trading filing for fiscal 2022
- AN2 Therapeutics, Inc. S-1 2026ANTX S-1 2026: registration statement for fiscal 2026
- AN2 Therapeutics, Inc. S-1 2025ANTX S-1 2025: registration statement for fiscal 2025
- AN2 Therapeutics, Inc. S-1 2024ANTX S-1 2024: registration statement for fiscal 2024
- AN2 Therapeutics, Inc. S-1 2023ANTX S-1 2023: registration statement for fiscal 2023
- AN2 Therapeutics, Inc. S-1 2022ANTX S-1 2022: registration statement for fiscal 2022
- AN2 Therapeutics, Inc. 13F 2026ANTX 13F 2026: institutional holdings for fiscal 2026
- AN2 Therapeutics, Inc. 13F 2025ANTX 13F 2025: institutional holdings for fiscal 2025
- AN2 Therapeutics, Inc. 13F 2024ANTX 13F 2024: institutional holdings for fiscal 2024
- AN2 Therapeutics, Inc. 13F 2023ANTX 13F 2023: institutional holdings for fiscal 2023
- AN2 Therapeutics, Inc. 13F 2022ANTX 13F 2022: institutional holdings for fiscal 2022
More companies